Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|
Free Cash Flow | ($57.3M) | ($76.7M) | ($6,712.0K) | ($39.4M) | ($33.8M) | $47.0M |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Hims & Hers Health, Inc.'s last 12-month Free Cash Flow is $151.6M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Hims & Hers Health, Inc.'s Free Cash Flow growth was 463.9%. The average annual Free Cash Flow growth rates for Hims & Hers Health, Inc. have been N/A over the past three years, N/A over the past five years.
Over the last year, Hims & Hers Health, Inc.'s Free Cash Flow growth was 463.9%, which is higher than industry growth of 1.3%. It indicates that Hims & Hers Health, Inc.'s Free Cash Flow growth is Good.